Insider · CIK 0001494386

Ende Eric J

Reports to the SEC for 5 companies · DUBLIN 2, L2

sec.gov

Transactions

Companies

Filings

CIK

0001494386

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−60K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLCD Disposition to Issuer	Director	DDisposition to Issuer	−220K sh	$21.00	−$4.62M	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−33K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−42K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−42K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−42K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,057 sh	—	—	0
2025-07-29	AVDLAVADEL PHARMACEUTICALS PLCA Award	Director	AAward	+11K sh	—	—	219,900
2025-07-29	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2025-01-13	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director	PPurchase	+30K sh	$7.84	+$235K	208,900
2024-07-30	AVDLAVADEL PHARMACEUTICALS PLCA Award	Director	AAward	+11K sh	—	—	178,900
2024-07-30	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2023-11-01	MTNBMatinas BioPharma Holdings, Inc. · Stock option (right to buy)A Award	Director	AAward	+437K sh	—	—	437,244
2023-08-01	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)A Award	Director	AAward	+33K sh	—	—	33,000
2023-05-18	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director	PPurchase	+13K sh	$13.93	+$181K	167,900
2022-11-22	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director	PPurchase	+20K sh	$7.80	+$156K	154,900
2022-11-14	MTNBMatinas BioPharma Holdings, Inc. · Stock option (right to buy)A Award	Director	AAward	+143K sh	—	—	142,657
2022-09-09	NeuBase Therapeutics, Inc.Stock option (right to buy)A Award	Director	AAward	+37.6K sh	—	—	37,600
2022-08-03	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)A Award	Director	AAward	+42K sh	—	—	42,000
2022-06-01	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director	PPurchase	+20K sh	$2.27	+$45.5K	134,900
2022-05-31	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director	PPurchase	+15K sh	$2.16	+$32.4K	114,900
2022-05-27	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director	PPurchase	+15K sh	$2.45	+$36.7K	99,900
2022-01-01	NeuBase Therapeutics, Inc.Stock option (right to buy)A Award	Director	AAward	+166K sh	—	—	165,803
2021-11-01	MTNBMatinas BioPharma Holdings, Inc. · Stock option (right to buy)A Award	Director	AAward	+90.9K sh	—	—	90,882
2021-08-03	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)A Award	Director	AAward	+42K sh	—	—	42,000
2021-06-19	MTNBMatinas BioPharma Holdings, Inc.C Conversion	Director	CConversion	+24K sh	—	—	144,092
2021-06-19	MTNBMatinas BioPharma Holdings, Inc.J Other	Director	JOther	+4,800 sh	—	—	120,092
2021-06-19	MTNBMatinas BioPharma Holdings, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−12 sh	—	—	0
2020-11-02	MTNBMatinas BioPharma Holdings, Inc. · Stock option (right to buy)A Award	Director	AAward	+123K sh	—	—	122,605
2020-09-17	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director	PPurchase	+17K sh	$5.79	+$98.4K	84,900
2020-08-13	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director	PPurchase	+1,200 sh	$7.74	+$9,288	64,100
2020-08-13	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director	PPurchase	+3,800 sh	$7.80	+$29.6K	67,900
2020-08-12	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director	PPurchase	+15K sh	$7.76	+$116K	62,900
2020-08-07	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)A Award	Director	AAward	+42K sh	—	—	42,000
2020-06-23	MTNBMatinas BioPharma Holdings, Inc.J Other	Director	JOther	+3,600 sh	—	—	115,292
2020-06-19	PROGENICS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2020-06-19	PROGENICS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.4K sh	—	—	0
2019-12-13	PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+16.4K sh	—	—	16,393
2019-12-13	PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2019-12-04	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director	PPurchase	+10K sh	$5.97	+$59.7K	47,900
2019-11-15	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director	PPurchase	+10K sh	$4.98	+$49.8K	37,900
2019-11-01	MTNBMatinas BioPharma Holdings, Inc. · Stock option (right to buy)A Award	Director	AAward	+107K sh	—	—	107,416
2019-08-20	MTNBMatinas BioPharma Holdings, Inc.P Purchase	Director	PPurchase	+20K sh	$0.66	+$13.2K	109,292
2019-08-19	MTNBMatinas BioPharma Holdings, Inc.P Purchase	Director	PPurchase	+20K sh	$0.68	+$13.7K	89,292
2019-08-07	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000
2019-06-21	MTNBMatinas BioPharma Holdings, Inc.J Other	Director	JOther	+2,400 sh	—	—	111,692
2019-05-22	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (right to buy)A Award	Director	AAward	+8,057 sh	—	—	8,057
2019-01-31	AVDLAVADEL PHARMACEUTICALS PLCA Award	Director	AAward	+27.9K sh	—	—	27,900

Recent filings

Accepted (ET)
Feb 124
Ende Eric J0001104659-26-014442
SEC(opens sec.gov)
Jul 314
Ende Eric J0001104659-25-072685
SEC(opens sec.gov)
Jan 144
Ende Eric J0001104659-25-003451
SEC(opens sec.gov)
Aug 14
Ende Eric J0001104659-24-084938
SEC(opens sec.gov)
Nov 34
Ende Eric J0001493152-23-039335
SEC(opens sec.gov)
Aug 34
Ende Eric J0001104659-23-087293
SEC(opens sec.gov)
May 194
Ende Eric J0001104659-23-062694
SEC(opens sec.gov)
Nov 234
Ende Eric J0001104659-22-121721
SEC(opens sec.gov)
Nov 164
Ende Eric J0001493152-22-032690
SEC(opens sec.gov)
Sep 124
Ende Eric J0001104659-22-099283
SEC(opens sec.gov)

Companies

Address

C/O AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE

DUBLIN 2, L2, D02 T380